|
| 38007586 | Impact of age and comorbidities on the efficacy and tolerability of bosutinib in previously treated patients with chronic myeloid leukemia: results from the phase 4 BYOND study. | Leukemia | 2024 |
| 36828867 | Clinicohematologic and molecular response of essential thrombocythemia patients treated with pegylated interferon-α: a multi-center study of the German Study Group-Myeloproliferative Neoplasms (GSG-MPN). | Leukemia | 2023 |
| 37958431 | Impact of Human Papillomavirus-Negative Dominance in Oropharyngeal Cancer on Overall Survival: A Population-Based Analysis in Germany from 2018 to 2020. | Cancers (Basel) | 2023 |
| 37592092 | Step-in dosing of bosutinib in pts with chronic phase chronic myeloid leukemia (CML) after second-generation tyrosine kinase inhibitor (TKI) therapy: results of the Bosutinib Dose Optimization (BODO) Study. | Ann Hematol | 2023 |
| 37794101 | European LeukemiaNet laboratory recommendations for the diagnosis and management of chronic myeloid leukemia. | Leukemia | 2023 |
| 37509471 | Clinical Results of Transarterial Radioembolization (TARE) with Holmium-166 Microspheres in the Multidisciplinary Oncologic Treatment of Patients with Primary and Secondary Liver Cancer. | Biomedicines | 2023 |
| 37875494 | Nivolumab and ipilimumab in recurrent or refractory cancer of unknown primary: a phase II trial. | Nat Commun | 2023 |
| 37115093 | Planning adaptive treatment by longitudinal response assessment implementing MR imaging, liquid biopsy and analysis of microenvironment during neoadjuvant treatment of rectal cancer (PRIMO). | Medicine (Baltimore) | 2023 |
| 37410174 | Knowledge, feelings, and willingness to use palliative care in cancer patients with hematologic malignancies and solid tumors: a prospective, cross-sectional study in a comprehensive cancer center in Germany. | Support Care Cancer | 2023 |
| 37237078 | Genetic separation of chronic myeloid leukemia stem cells from normal hematopoietic stem cells at single-cell resolution. | Leukemia | 2023 |
| 37139709 | Molecular-defined clonal evolution in patients with classical myeloproliferative neoplasms. | Br J Haematol | 2023 |
| 37366890 | Long-Term Total Neoadjuvant Therapy Leads to Impressive Response Rates in Rectal Cancer: Results of a German Single-Center Cohort. | Curr Oncol | 2023 |
| 36781500 | Pomalidomide combinations are a safe and effective option after daratumumab failure. | J Cancer Res Clin Oncol | 2023 |
| 34228225 | Complementary and alternative medicine (CAM) supplements in cancer outpatients: analyses of usage and of interaction risks with cancer treatment. | J Cancer Res Clin Oncol | 2022 |
| 35740490 | Role of Intraparotid and Neck Lymph Node Metastasis in Primary Parotid Cancer Surgery: A Population-Based Analysis. | Cancers (Basel) | 2022 |
| 35804871 | Early Mortality among Patients with Head and Neck Cancer Diagnosed in Thuringia, Germany, between 1996 and 2016-A Population-Based Study. | Cancers (Basel) | 2022 |
| 35676453 | Impact of BCR::ABL1 transcript type on RT-qPCR amplification performance and molecular response to therapy. | Leukemia | 2022 |
| 35614319 | Standardization of molecular monitoring of CML: results and recommendations from the European treatment and outcome study. | Leukemia | 2022 |
| 35705004 | Sex-Disaggregated Analysis of Biology, Treatment Tolerability, and Outcome of Multiple Myeloma in a German Cohort. | Oncol Res Treat | 2022 |
| 35488907 | No impact of time to treatment initiation for head and neck cancer in a tertiary university center in 2003, 2008 and 2013. | Eur Arch Otorhinolaryngol | 2022 |
| 35362552 | A phase II trial to evaluate the combination of pixantrone and obinutuzumab for patients with relapsed aggressive lymphoma: Final results of the prospective, multicentre GOAL trial. | Br J Haematol | 2022 |
| 35908105 | Droplet digital PCR for the detection of second-generation tyrosine kinase inhibitor-resistant BCR::ABL1 kinase domain mutations in chronic myeloid leukemia. | Leukemia | 2022 |
| 35902731 | ASXL1 mutations predict inferior molecular response to nilotinib treatment in chronic myeloid leukemia. | Leukemia | 2022 |
| 35979940 | Clonal haematopoiesis of indeterminate potential-related mutations and outcome in dilated and ischaemic cardiomyopathy. | ESC Heart Fail | 2022 |
| 33864520 | Interactions in cancer treatment considering cancer therapy, concomitant medications, food, herbal medicine and other supplements. | J Cancer Res Clin Oncol | 2022 |
| 34807283 | The log odds of positive neck lymph nodes is a superior lymph node predictor for overall survival in head and neck cancer: a population-based analysis in Germany. | Eur Arch Otorhinolaryngol | 2022 |
| 32577845 | Durable remission with ruxolitinib in a chronic neutrophilic leukemia patient harboring a truncation and membrane proximal CSF3R compound mutation. | Ann Hematol | 2021 |
| 33517469 | Systemic therapy for recurrent and/or metastatic head and neck cancer: a population-based healthcare research study in Thuringia, Germany. | J Cancer Res Clin Oncol | 2021 |
| 33543336 | Quality of life, symptoms and dietary habits in oncology outpatients with malnutrition: A cross-sectional study. | Med Oncol | 2021 |
| 33677711 | Assessment of individual molecular response in chronic myeloid leukemia patients with atypical BCR-ABL1 fusion transcripts: recommendations by the EUTOS cooperative network. | J Cancer Res Clin Oncol | 2021 |
| 33676500 | Improved gene delivery to K-562 leukemia cells by lipoic acid modified block copolymer micelles. | J Nanobiotechnology | 2021 |
| 33735175 | Ultra-precise quantification of mRNA targets across a broad dynamic range with nanoreactor beads. | PLoS One | 2021 |
| 34889388 | TKI discontinuation in CML: how do we make more patients eligible? How do we increase the chances of a successful treatment-free remission? | Hematology Am Soc Hematol Educ Program | 2021 |
| 34785796 | Publisher Correction: SIRT7: an influence factor in healthy aging and the development of age-dependent myeloid stem-cell disorders. | Leukemia | 2021 |
| 34050959 | Long-Term Facial Nerve Outcome in Primary Parotid Cancer Surgery: A Population-Based Analysis. | Laryngoscope | 2021 |
| 34255138 | Correction to: Molecular remission using three monoclonal antibodies followed by allogeneic bone marrow transplantation in an infant with refractory ALL. | Ann Hematol | 2021 |
| 33299059 | Melphalan 200â¿¿mg/m<sup>2</sup> does not increase toxicity and improves survival in comparison to reduced doses of melphalan in multiple myeloma patients. | Bone Marrow Transplant | 2021 |
| 32193626 | A 19-year-old patient with atypical chronic myeloid leukemia. | Ann Hematol | 2020 |
| 31836850 | Molecular-defined clonal evolution in patients with chronic myeloid leukemia who were exposed to ionizing radiation following the Chernobyl nuclear disaster. | Leukemia | 2020 |
| 32076823 | Hemophagocytic lymphohistiocytosis in adults: collaborative analysis of 137 cases of a nationwide German registry. | J Cancer Res Clin Oncol | 2020 |
| 31957290 | Knockout of LASP1 in CXCR4 expressing CML cells promotes cell persistence, proliferation and TKI resistance. | J Cell Mol Med | 2020 |
| 32075106 | Phosphorylation-Dependent Differences in CXCR4-LASP1-AKT1 Interaction between Breast Cancer and Chronic Myeloid Leukemia. | Cells | 2020 |
| 31949266 | Correction: The acetyltransferase GCN5 maintains ATRA-resistance in non-APL AML. | Leukemia | 2020 |
| 32067128 | Molecular remission using three monoclonal antibodies followed by allogeneic bone marrow transplantation in an infant with refractory ALL. | Ann Hematol | 2020 |
| 32041606 | Integration of mathematical model predictions into routine workflows to support clinical decision making in haematology. | BMC Med Inform Decis Mak | 2020 |
| 33218009 | Gender Disparities in Epidemiology, Treatment, and Outcome for Head and Neck Cancer in Germany: A Population-Based Long-Term Analysis from 1996 to 2016 of the Thuringian Cancer Registry. | Cancers (Basel) | 2020 |
| 33239784 | Splicing factor YBX1 mediates persistence of JAK2-mutated neoplasms. | Nature | 2020 |
| 33038988 | CML - Not only BCR-ABL1 matters. | Best Pract Res Clin Haematol | 2020 |
| 32913887 | Polymethine Dye-Functionalized Nanoparticles for Targeting CML Stem Cells. | Mol Ther Oncolytics | 2020 |
| 32650416 | EZH2 in Myeloid Malignancies. | Cells | 2020 |